507 related articles for article (PubMed ID: 22975536)
1. Short-term effects of β-adrenergic antagonists and methimazole in new-onset thyrotoxicosis caused by Graves' disease.
Tagami T; Yambe Y; Tanaka T; Tanaka T; Ogo A; Yoshizumi H; Kaise K; Higashi K; Tanabe M; Shimazu S; Usui T; Shimatsu A; Naruse M;
Intern Med; 2012; 51(17):2285-90. PubMed ID: 22975536
[TBL] [Abstract][Full Text] [Related]
2. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
3. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Popoveniuc G; Sharma M; Devdhar M; Wexler JA; Carroll NM; Wartofsky L; Burman KD
Thyroid; 2010 Sep; 20(9):1015-8. PubMed ID: 20718680
[TBL] [Abstract][Full Text] [Related]
4. [Assessment of early immunosuppressive therapy in the prevention of complications of Graves' disease].
Huszno B; Trofimiuk M; Gołkowski F; Plinta T; Szybiński Z
Przegl Lek; 2004; 61(8):868-71. PubMed ID: 15789920
[TBL] [Abstract][Full Text] [Related]
5. Neonatal Thyrotoxicosis.
Samuels SL; Namoc SM; Bauer AJ
Clin Perinatol; 2018 Mar; 45(1):31-40. PubMed ID: 29406005
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of Graves' disease and unilateral functioning Struma ovarii: a case report.
Sitasuwan T; Hanamornroongruang S; Peerapatdit T; Thongtang N
BMC Endocr Disord; 2015 Nov; 15():68. PubMed ID: 26530865
[TBL] [Abstract][Full Text] [Related]
7. Neonatal thyrotoxicosis caused by maternal autoimmune hyperthyroidism.
Correia MF; Maria AT; Prado S; Limbert C
BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25750228
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of Yingliu mixture combined with metimazole for treating diffuse goitre with hyperthyroidism and its impact on related cytokines.
Yang H; Cong Y; Wu T; Tang H; Ma M; Zeng J; Zhang W; Lian Z; Yang X
Pharm Biol; 2017 Dec; 55(1):258-263. PubMed ID: 27927064
[TBL] [Abstract][Full Text] [Related]
9. [Effects of methimazole on the evolution of the allergic rhinitis of patients with Graves' disease].
Valencia Zavala MP; Cortinas López L; Sánchez Olivas JA; Sánchez Olivas MA; Montes Montes J; Duarte Díaz RJ; León Oviedo C
Rev Alerg Mex; 2007; 54(3):71-6. PubMed ID: 17849791
[TBL] [Abstract][Full Text] [Related]
10. Thyrotoxic hypokalemic periodic paralysis is a rare but potentially fatal emergency: case report and literature review.
Gómez-Torres JY; Bravo-Llerena WE; Reyes-Ortiz LM; Valderrábano-Wagner RJ; Mariano-Mejías V; Brunet-Rodríguez H; Lemos-Ramírez JC
Bol Asoc Med P R; 2011; 103(2):67-74. PubMed ID: 22111475
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular complications secondary to Graves' disease: a prospective study from Ukraine.
Tsymbaliuk I; Unukovych D; Shvets N; Dinets A
PLoS One; 2015; 10(3):e0122388. PubMed ID: 25803030
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
13. Graves' disease in a mediastinal mass presenting after total thyroidectomy for nontoxic multinodular goiter: a case report.
Cunha FM; Rodrigues E; Oliveira J; Saavedra A; Vinhas LS; Carvalho D
J Med Case Rep; 2016 Mar; 10():70. PubMed ID: 27029843
[TBL] [Abstract][Full Text] [Related]
14. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
[TBL] [Abstract][Full Text] [Related]
15. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
Wu G; Jie Y; Situ Y
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):274-5. PubMed ID: 11798886
[TBL] [Abstract][Full Text] [Related]
16. A case of severe cholestatic jaundice associated with Graves' disease.
Soysal D; Tatar E; Solmaz S; Kabayeğit O; Tunakan M; Unsal B; Cevik C
Turk J Gastroenterol; 2008 Mar; 19(1):77-9. PubMed ID: 18386249
[No Abstract] [Full Text] [Related]
17. Repetitive monomorphic ventricular tachycardia as a manifestation of suboptimally treated thyrotoxicosis.
Chandra PA; Vallakati A; Chandra AB; Pednekar M; Ghosh J
Am Heart Hosp J; 2010; 8(2):E113-4. PubMed ID: 22022738
[TBL] [Abstract][Full Text] [Related]
18. [Catecholamines and thyrotoxicosis].
Odinokova VA; Mravian SR
Sov Med; 1991; (2):36-41. PubMed ID: 1711717
[No Abstract] [Full Text] [Related]
19. A 6-year follow-up of a randomized prospective trial comparing methimazole treatment with or without exogenous L-thyroxine in Chinese patients with Graves' disease.
Liu X; Qiang W; Liu X; Liu L; Liu S; Gao A; Gao S; Shi B
Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):564-7. PubMed ID: 25140995
[TBL] [Abstract][Full Text] [Related]
20. Effects of high and low doses of methimazole in patients with Graves' thyrotoxicosis.
Benker G; Reinwein D; Creutzig H; Hirche H; Alexander WD; McCruden D; Galvan G; Kahály G; Beyer J; Lazarus JH
Acta Endocrinol Suppl (Copenh); 1987; 281():312-7. PubMed ID: 3303792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
